CLAIM #2955 · Abbott Laboratories (ABT) · 2022Q3 earnings call · Oct 18, 2022 · due Mar 31, 2023
“So we'll start to see the share recovery build month-over-month.”
Robert Ford · CEO
PENDING
graded after results covering Mar 31, 2023 are reported
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2022Q3 earnings call.